Matt Hantzmon is listed as a director on 1 SEC Form D filing by 1 issuer in Jun 2013: HemoSonics, LLC (Charlottesville, VA — other health care — 2013; $15M reported sold to 34 investors).
What this means One deal on file with the SEC, filed Jun 2013. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside David Freed (1 shared filing), Francesco Viola (1 shared filing), Jonathan Sackier (1 shared filing) and Mark Wheeler (1 shared filing).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Matt. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 1 public filing for Matt Hantzmon and found 1 difference, 1 worth asking the sponsor about: Form D filed 158 days after the first sale.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.